Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Arias, S. Riestra, R. DeFrancisco, A. Pando, J.J. Palacios, P. Escalante, J. Belda, L. Molinos, M. García-Clemente, B. Palomo, L. Rodrigo, A. Prieto, A. Losada, P. Casan (Oviedo, Rochester, Valencia, Spain). Treatment in inflammatory bowel disease affects IGRA performance. Eur Respir J 2012; 40: Suppl. 56, 427

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary involvement of inflammatory bowel disease in children and adult patients Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Functional and inflammatory bowel diseases in patients with COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Increased incidence of inflammatory bowel disease in Québec residents with airway diseases Source: Eur Respir J 2015; 45: 962-968 Year: 2015 Lung function in children with inflammatory bowel diseases Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Airway and lung involvement in inflammatory bowel disease Source: Eur Respir Monogr 2019; 86: 228-261 Year: 2019 Inflammatory bowel diseases in COPD patients. Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Pulmonary function in children with inflammatory bowel disease do not differ from healthy population Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011 Pulmonary involvement in inflammatory bowel disease Source: Annual Congress 2010 - Pulmonary involvement in disorders of the gastrointestinal system Year: 2010 Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004 Bronchial hyperreactivity in patients with inflammatory bowel disease Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003 Diffuse parenchymal lung inflammation response in patients with inflammatory bowel disease Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005 Bronchiectasis associated with inflammatory bowel disease Source: Eur Respir Mon 2011; 52: 163-177 Year: 2011 Inflammatory bowel disease and risk of mortality in COPD Source: Eur Respir J 2016; 47:1357-1364 Year: 2016 Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 Year: 2018 Inflammatory bowel diseases and respiratory manifestations Source: International Congress 2017 – Respiratory manifestations of gastrointestinal diseases Year: 2017